BioMarin Pharmaceutical Inc. Claimed Company
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact. read more
HR or Marketing? Claim Your Free Employer Account
BioMarin Pharmaceutical Inc. VP of Investor Relations Salary
The average BioMarin Pharmaceutical Inc. VP of Investor Relations earns an estimated $127,563 annually. BioMarin Pharmaceutical Inc. VP of Investor Relations compensation is $3,845 less than the US average for a VP of Investor Relations.
Last updated 24 days ago.
$77k
$120k
$129k
$225k
$127,563
Average Compensation
- $127,563
- avg. base
VP of Investor Relations Salaries at BioMarin Pharmaceutical Inc.
Compensation at BioMarin Pharmaceutical Inc. by Department
How VPs of Investor Relations at BioMarin Pharmaceutical Inc. Rate Their Compensation
The majority of VPs of Investor Relations at BioMarin Pharmaceutical Inc. believe they're compensated fairly. 100% of VPs of Investor Relations at BioMarin Pharmaceutical Inc. say they receive annual bonuses, and the vast majority (78%) are satisfied with their benefits. See more compensation ratings at BioMarin Pharmaceutical Inc.
VP of Investor Relations Salaries at Similar Size Companies
×